LEXARIA BIOSCIENCE CORP (LEXX)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$14.15+14.85%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · LEXX
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Aug 2025 | Aug 2024 | Aug 2023 | Aug 2022 | Aug 2021 | Aug 2020 | Aug 2019 | Aug 2018 | Aug 2017 | Aug 2016 | Aug 2015 | Aug 2014 | Aug 2013 | Aug 2012 | Aug 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | — | 0.7 | 0.5 | 0.2 | 0.3 | 0.7 | 0.3 | 0.2 | 0.4 | 0.1 | 0.0 | 0.0 | — | 1.1 | 1.4 | 1.1 |
| Total Revenues | — | 0.7 | 0.5 | 0.2 | 0.3 | 0.7 | 0.3 | — | — | — | — | — | — | — | — | — |
| Cost of Revenues | — | 0.0 | 0.0 | 0.0 | 0.1 | 0.2 | 0.1 | 0.0 | 0.0 | — | — | — | — | 0.8 | 0.8 | 0.7 |
| Gross Profit | — | 0.7 | 0.5 | 0.2 | 0.2 | 0.5 | 0.2 | 0.2 | 0.4 | 0.0 | (0.0) | (0.0) | — | 0.3 | 0.6 | 0.5 |
| Operating Expenses & Income | ||||||||||||||||
| R&D Expenses | 4.0 | 8.2 | 2.4 | 3.7 | 1.8 | 1.3 | 0.4 | 0.6 | 0.5 | 0.1 | 0.0 | 0.1 | — | — | — | — |
| Operating Income | (7.7) | (11.9) | (5.8) | (6.5) | (6.6) | (5.7) | (4.0) | (4.2) | (6.6) | — | (1.3) | (2.0) | — | — | — | — |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | — | — | — | — | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | — | 0.3 | 0.2 | 0.2 |
| Other Non-Operating Income / Expenses | (0.0) | (0.0) | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | — | (11.9) | (5.8) | (6.7) | (7.4) | (4.2) | (4.0) | (4.2) | (6.6) | — | — | — | — | — | — | — |
| Income Tax Expense | — | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | — | — | — | — | — |
| Net Income | ||||||||||||||||
| Minority Interest | (0.0) | (0.0) | (0.0) | (0.0) | (0.1) | (0.2) | (0.2) | — | (0.0) | (0.1) | (0.1) | (0.2) | — | — | — | — |
| Net Income | (7.7) | (11.9) | (5.8) | (6.7) | (7.3) | (4.0) | (4.1) | 4.1 | 6.6 | (1.9) | (1.2) | (2.0) | (0.6) | — | — | (0.5) |
| Per Share | ||||||||||||||||
| Diluted EPS | (0.31) | (0.66) | (0.47) | (1.01) | — | — | — | — | — | — | — | — | — | — | — | (0.04) |
| Diluted Weighted Avg Shares | 24.8 | 18.0 | 12.4 | 6.6 | — | — | — | — | — | — | — | — | — | — | — | 14.2 |
| Supplemental | ||||||||||||||||
| EBITDA | — | (11.8) | (5.7) | (6.4) | (6.5) | (5.6) | — | — | — | — | — | — | — | — | — | — |
| EBIT | (7.7) | (11.9) | (5.8) | (6.5) | (6.6) | (5.7) | (4.0) | (4.2) | (6.6) | — | (1.3) | (2.0) | — | — | — | — |
| Effective Tax Rate | — | — | — | — | 0.0% | -0.1% | -0.1% | -0.4% | 0.0% | — | — | — | — | — | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.